July 26, 2017
ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem cell therapy development company has announced the appointment of Nplus1 Singer Advisory LLP (‘N+1 Singer’) as its joint broker with immediate effect.
Current Market Cap: £55 million
Life sciences is one of the core sector we cover, along with Technology, Healthcare, Industrials, Consumer and General Retail, Media, Support Services, Financials and Investment Funds. To learn more about our clients, click here.